
Bloomsbury Natural Capital
AI Verified
United Kingdom
Venture Capital
http://bloomsburynatural.capital
97, Judd Street, King's Cross, London Borough of Camden, London, Greater London, England, WC1H 9NE, United Kingdom
2021
Criteria | Requirements | Match |
---|---|---|
Regions | North America, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Bloomsbury Natural Capital operates as a profit-driven investment entity focused on companies that simultaneously deliver commercial returns while enhancing carbon sequestration and biodiversity. Under the leadership of Chairman Peter Hollands and Directors Martin Hollands and Barbara Sotowicz, with Simon Benney providing IT and data advisory support, BNC strategically targets early-stage ventures with significant environmental impact potential. The firm specializes in initial investments at Seed and Series A funding stages, typically acquiring 5% equity stakes that may expand to 10-25% in later financing rounds. BNC primarily pursues opportunities with pre-money valuations ranging from £2.5 million to £15 million, demonstrating a clear investment framework for sustainable business models.
The investment portfolio currently features a 3% stake in Cascadia Seaweed, a Canadian enterprise where Martin Hollands serves as Senior Advisor on Ecosystem Services and Restorative Aquaculture. Cascadia has developed a diversified business model encompassing seaweed cultivation, production of liquid extracts through its Plant Health Division, and bio-stimulant sales. The company is also advancing innovative solutions for reducing livestock methane emissions via its Animal Health Division while delivering ecosystem services across operations in Canada and Kenya, exemplifying BNC's commitment to businesses with multiple environmental benefits.
BNC has further expanded its portfolio with a 1% equity position in Switzerland-based Xilva AG, where Martin Hollands represents BNC on the board. Xilva provides sophisticated AI-enhanced environmental screening for forest investments through two primary services: 'Xilva FOREST+ PORTFOLIO,' which catalogs and rigorously evaluates high-integrity forests, and 'Xilva GRADE,' which offers comprehensive forest evaluation methodologies tailored for investors, project developers, and corporate buyers. This investment aligns with BNC's strategy of supporting technological innovations that improve environmental assessment capabilities and facilitate more sustainable investment decisions in natural capital markets.
The firm operates within a broader ecosystem of environmentally focused investments through its parent company, Bloomsbury Minerals Economics, which holds a 26% stake in Skarn Associates (specializing in mining energy usage and greenhouse gas emissions research) and an indirect 19.5% interest in Skarn Water (focused on water stewardship in metal mining operations). Additionally, BNC's sister company, Bloomsbury Information Capital, maintains investments in Minviro (4% equity), which provides life cycle assessments for metals, and Neo Eco (3.3% equity), which has developed financially integrated sustainability reporting software. This interconnected investment structure demonstrates BNC's comprehensive approach to supporting the entire value chain of sustainable natural resource management.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Bloomsbury Natural Capital maintains its global headquarters in United Kingdom, serving as the strategic center for its operations. The company's primary corporate offices are located at 97, Judd Street, King's Cross, London Borough of Camden, London, Greater London, England, WC1H 9NE, United Kingdom.
Bloomsbury Natural Capital focuses its investment activities on companies operating in the following stages: Seed. Bloomsbury Natural Capital provides strategic capital and expertise to support promising businesses at these critical phases of development.
Bloomsbury Natural Capital maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Western Europe.
Bloomsbury Natural Capital was established in 2021, marking the beginning of its journey as an investment firm.
Bloomsbury Natural Capital is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.